Issue navigation
Volume 32, Issue 20, October 2011
CardioPulse
CardioPulse Articles
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2465–2472, https://doi.org/10.1093/eurheartj/ehr318
Editorials
Long-term application of vitamin K antagonists, more harm than good? The additional value of imaging
Nico Bruining and Ron T. van Domburg
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2473–2475, https://doi.org/10.1093/eurheartj/ehr241
Worsening kidney function in decompensated heart failure: treat the heart, don't mind the kidney
Piero Ruggenenti and Giuseppe Remuzzi
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2476–2478, https://doi.org/10.1093/eurheartj/ehr242
ESC COMMENTARIES
ESC clinical trial update
Long-term results from statin trials: answers but more unresolved questions
Guy G. De Backer
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2479–2480, https://doi.org/10.1093/eurheartj/ehr303
Left ventricular remodelling in systolic heart failure using ivabradine. Slower is smaller is better?
Friedrich Fruhwald and Burkert Pieske
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2481–2482, https://doi.org/10.1093/eurheartj/ehr317
Chronic right ventricular pacing, adverse remodelling, and CRT: an ounce of prevention?
Kenneth Dickstein
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2483–2485, https://doi.org/10.1093/eurheartj/ehr337
ESC hot line
On the cutting edge of acute coronary syndromes: adding oral factor Xa-inhibition with darexaban to dual antiplatelet therapy: the RUBY-1 trial
Steen D. Kristensen
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2486–2488, https://doi.org/10.1093/eurheartj/ehr314
CARDIOVASCULAR FLASHLIGHT
A marker of mayhem: macrovolt T-wave alternans preceding polymorphic ventricular tachycardia
Vincent Floré and others
European Heart Journal, Volume 32, Issue 20, October 2011, Page 2488, https://doi.org/10.1093/eurheartj/ehr207
Reviews
Frontiers in cardiovascular medicine
Early detection of pulmonary vascular disease in pulmonary arterial hypertension: time to move forward
Edmund M.T. Lau and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2489–2498, https://doi.org/10.1093/eurheartj/ehr160
CARDIOVASCULAR FLASHLIGHT
Rupturing aortic dissection
Long Jiang Zhang and Guang Ming Lu
European Heart Journal, Volume 32, Issue 20, October 2011, Page 2498, https://doi.org/10.1093/eurheartj/ehr206
Reviews
Novel therapeutic concepts
Hypertension management 2011: optimal combination therapy
Peter S. Sever and Franz H. Messerli
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2499–2506, https://doi.org/10.1093/eurheartj/ehr177
FASTTRACK
ESC clinical trial update
Effects of selective heart rate reduction with ivabradine on left ventricular remodelling and function: results from the SHIFT echocardiography substudy
Jean-Claude Tardif and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2507–2515, https://doi.org/10.1093/eurheartj/ehr311
The relationship between ventricular electrical delay and left ventricular remodelling with cardiac resynchronization therapy
Michael R. Gold and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2516–2524, https://doi.org/10.1093/eurheartj/ehr329
CARDIOVASCULAR FLASHLIGHT
Double mechanical prosthesis, correct international normalized ratio, and giant atrial mass
Victor Manuel Hidalgo-Olivares and others
European Heart Journal, Volume 32, Issue 20, October 2011, Page 2524, https://doi.org/10.1093/eurheartj/ehr216
FASTTRACK
ESC clinical trial update
The Anglo-Scandinavian Cardiac Outcomes Trial: 11-year mortality follow-up of the lipid-lowering arm in the UK
Peter S. Sever and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2525–2532, https://doi.org/10.1093/eurheartj/ehr333
Biventricular pacing is superior to right ventricular pacing in bradycardia patients with preserved systolic function: 2-year results of the PACE trial
Joseph Yat-Sun Chan and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2533–2540, https://doi.org/10.1093/eurheartj/ehr336
ESC hot line
RUBY-1: a randomized, double-blind, placebo-controlled trial of the safety and tolerability of the novel oral factor Xa inhibitor darexaban (YM150) following acute coronary syndrome
Ph. Gabriel Steg and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2541–2554, https://doi.org/10.1093/eurheartj/ehr334
Clinical Research
Prevention and epidemiology
Patients using vitamin K antagonists show increased levels of coronary calcification: an observational study in low-risk atrial fibrillation patients
Bob Weijs and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2555–2562, https://doi.org/10.1093/eurheartj/ehr226
Heart failure/cardiomyopathy
Changes in renal function during hospitalization and soon after discharge in patients admitted for worsening heart failure in the placebo group of the EVEREST trial
John E.A. Blair and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2563–2572, https://doi.org/10.1093/eurheartj/ehr238
CARDIOVASCULAR FLASHLIGHT
Shamrock aorta: unruptured sinus of Valsalva aneurysms in a patient with a prosthetic heart valve
Sercan Okutucu and others
European Heart Journal, Volume 32, Issue 20, October 2011, Page 2572, https://doi.org/10.1093/eurheartj/ehr208
Basic science
Dietary α-linolenic acid diminishes experimental atherogenesis and restricts T cell-driven inflammation
Stephan Winnik and others
European Heart Journal, Volume 32, Issue 20, October 2011, Pages 2573–2584, https://doi.org/10.1093/eurheartj/ehq501
Advertisement intended for healthcare professionals
Advertisement intended for healthcare professionals